They Just Don't Get...
Health Care: Drugs
Eurand N.V. (EURX: NASDAQ)
$11.98 0.01 | 0.08%
03/01/11 - 03:59 PM ET
15.63K / 221.70K
Vol / Avg. Vol:11.99 / 11.97
Open / Prev. Close:11.98 - 11.99
Today's Range:7.41 - 12.82
52 Wk Range:1.27%
Performance YTD:TheStreet Rating:
Portfolios with EURX
- Portfolio NameUser Type
- UserSnoops Millionaire Picks
Latest EURX Headlines from TheStreet
- Eurand CEO Discusses Q3 2010 Results  Earnings Call Transcript 11.05.10 | 08:11 pm
- Eurand N.V. Q2 2010 Earnings Call Transcript 08.06.10 | 03:08 pm
- Eurand N.V. Q1 2010 Earnings Call Transcript 05.14.10 | 07:05 pm
- Eurand Says FDA Approved Pancreatic Enzyme Zenpep 08.28.09 | 09:08 am
- Biotech Calendar: Key Dates and Events 08.18.09 | 09:08 am
- Eurand drug candidate gets special FDA status 03.10.09 | 09:03 am
- Health Winners & Losers: StemCells 11.10.08 | 03:11 pm
Press Releases for EURX
Partner Headlines for EURX
- Merger Arbitrage Mondays: February 14, 2011 - Seeking Alpha 02.14.11 | 09:02 am
- Axcan to Acquire Eurand - Analyst Blog - Zacks 12.03.10 | 03:12 pm
- Bearish MACD for Eurand - Tale of the Tape - Zacks 04.22.10 | 12:04 pm
- CHURCHILL DOWNS (CHDN) - Profit Tracks - Zacks 04.20.10 | 01:04 am
